Prices delayed by at least 15 minutes | Print
Diaceutics PLC (DXRX)
ORD GBP0.002This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides the pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine, enabled by DXRX The Diagnostic Network. DXRX is the diagnostic commercialization platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a network of labs. These solutions are helping the pharma companies commercialize their precision medicines, enhance their return on investment and ultimately improve patients' lives. Geographically, it operates in UK, North America, Europe, and Asia and Rest of World.
Address
55-59 Adelaide Street
Titanic Suites, Enterprise House
Antrim
Northern Ireland
GBR
BT2 8FE
Forecast key dates
| Name | Key Date |
|---|---|
| Diaceutics PLC Second Quarter Earnings Conference Call for 2026 | 2026-09-23T09:30:00 |
| Diaceutics PLC Second Quarter Earnings Results for 2026 | 2026-09-23T00:00:00 |
| Diaceutics PLC Annual General Meeting for 2026 | 2026-06-18T10:30:00 |
| Diaceutics PLC Annual Report for 2025 | 2026-05-21T00:00:00 |
| Diaceutics PLC Fourth Quarter Earnings Conference Call for 2025 | 2026-05-13T14:00:00 |
| Diaceutics PLC Fourth Quarter Earnings Results for 2025 | 2026-05-13T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Diaceutics PLC Second Quarter Earnings Conference Call for 2025 | 2025-09-23T09:30:00 |
| Diaceutics PLC Second Quarter Earnings Result for 2025 | 2025-09-23T00:00:00 |
| Diaceutics PLC Annual General Meeting for 2025 | 2025-06-18T10:30:00 |
| Diaceutics PLC Annual Report for 2024 | 2025-05-21T00:00:00 |
| Diaceutics PLC Fourth Quarter Earnings Conference Call for 2024 | 2025-05-13T14:00:00 |
| Diaceutics PLC Fourth Quarter Earnings Result for 2024 | 2025-05-13T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.